WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8301 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 1'7501 Child (under 5 years) mortality rate: 762

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 10'461  10'317  10'174  10'033  9'896  8'578  7'110  5'692 
Births 264  265  265  265  265  267  265  239 
Surviving infants 254  254  254  254  254  250  241  209 
Pop. less than 5 years 1'250  1'250  1'250  1'247  1'241  1'224  1'161  914 
Pop. less than 15 years 3'615  3'607  3'598  3'588  3'578  3'459  3'068  2'339 
Female 15-49 years 2'768  2'719  2'671  2'623  2'577  2'102  1'643  1'369 

Number of reported case

(Click for retrospective incidence data for Haiti)
Diphtheria 16  23 
Japanese encephalitis
Measles 992  1'414  507 
Mumps
Pertussis 14  913  812 
Polio* 20 
Rubella
Rubella (CRS)
Tetanus (neonatal) 15  40  143 
Tetanus (total)** 15  143  381 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Haiti)
Vaccine year result method % card seen                                                
BCG 2011  83  DHS   73  85  75  74  82  64  57  72  26 
DTP1 2011  88  DHS   73  85  90  99  95  75 
DTP3 2011  63  DHS   73  85  85  85  85  67  59  41 
DTP4         
IPV1         
HepB_BD         
HepB3          85  85 
Hib3          85  85 
JapEnc         
MCV1          85  80  69  58  45  80  31 
MCV2         
PCV1         
PCV3         
Pol3 2011  59  DHS   73  85  92  80  79  62  58  40 
Rota1          85 
Rota_last          85 
Rubella1          85  80  66  45 
TT2plus 2011  65  DHS   73  70  57  59  61  16 
PAB         
VAD1          91  99*  99*  36  91 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Haiti)
BCG 76  83  83  83  82  72  72 
DTP1 72  86  86  86  85  73  66  21 
DTP3 48  68  68  68  67  49  41 
HepB3 48  68 
HepB_BD
Hib3 48  68 
MCV1 53  65  65  65  64  55  31 
MCV2
PAB 81  76  76  70  70  41  39  14 
PCV3
Pol3 55  67  67  67  66  50  40 
Rota_last 40 

Number of districts in the country 140  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
89 
   
/
|
|
\
Greater or equal to 90% 19
From 80 to 89% 10
From 50 to 79% 35
Less than 50% 36
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT <1 year; Yes contraindication to the vaccine
DTwP 4-5 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Adult >= 12 years; Yes at risk
IPV Yes Children born to HIV positive mothers
MMR 12, 24 months; Yes
MR 9 months; Yes
OPV 6, 10, 14 weeks; 4-5 years; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +4 weeks; +6 months; +1, +1 years; Yes pregnant women and Children >7 years of age
VitaminA 6,12, 18, 24, 30, 36 months; Yes
YF Yes >Y1 travelling to endemic countries

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015    2009-2013  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number   105    36    140  133 

System performance

Total Nº districts in country number 140  140  144  141  133  140  133 
Nº districts with DTP3 coverage >=80% number 40  80  68  70  91  62  38 
% of districts with DTP3 coverage >=80% From 0 to 100% 29  57  47  50  68  44  29 
Nº districts with measles (MCV1) coverage >=95% number 13  49  26  21  61 
% of districts with MCV1 coverage >=95% From 0 to 100% 35  18  15  46 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No    Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%           10 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    No  Yes       

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.